Navigation Links
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Date:5/1/2012

096PROPERTY, PLANT AND EQUIPMENT, NET

300,052

297,731GOODWILL

2,560,043

2,558,041OTHER INTANGIBLES, NET

2,416,921

2,504,124OTHER ASSETS

136,784

144,591TOTAL ASSETS

$
,887,210

$
7,292,583LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES:Accounts payable and accrued expenses

$
972,451

$
993,216Other current liabilities

108,152

128,562Total current liabilities

$
,080,603

$
,121,778DEFERRED INCOME TAXES

573,760

617,677LONG-TERM DEBT, LESS CURRENT PORTION, NET

3,197,015

3,424,329OTHER LIABILITIES

85,947

89,208STOCKHOLDERS' EQUITY:Total Endo Pharmaceuticals Holdings Inc. stockholders' equity

$
,889,133

$
,977,690Noncontrolling interests

60,752

61,901Total stockholders' equity

$
,949,885

$
2,039,591TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$
,887,210

$
7,292,583The following table presents unaudited condensed consolidated statement of cash flow data for the three months ended March 31, 2012 and 2011:20122011OPERATING ACTIVITIES:Consolidated net income,

$
(74,525)

$
8,295Adjustments to reconcile consolidated net income to net cash provided by operating activities:Depreciation and amortization

66,957

47,741Stock-based compensation

14,518

7,416Amortization of debt issuance costs and premium / discount

7,868

5,997Other

20,982

(1,284)Changes in assets and liabilities which provided cash:

(48,862)

2,893Net cash (used in) provided by operating activities

(13,062)

131,058INVESTING ACTIVITIES:Purchases of property, plant and equipment, net

(28,921)

(12,561)Other

(5,000)

(710)Net cash used in investing activ
'/>"/>

SOURCE Endo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Hospira Reports First-Quarter 2012 Results
2. Luminex Corporation Reports First Quarter 2012 Results
3. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
4. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Cepheid Reports 2012 First Quarter Results
11. Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Depomed, ... it intends to offer, subject to market and other ... Notes due 2021 (the "Notes"). Depomed, Inc. ("Depomed") expects ... option to purchase up to an additional $34.5 million ... Co. LLC and RBC Capital Markets, LLC will act ...
(Date:9/2/2014)... AUSTIN, Texas , Sept. 2, 2014 /PRNewswire/ ... Phase III study being conducted in the US ... a True Human™ monoclonal antibody therapy, is being ... is further complicated with cachexia. The primary endpoint ... in Xilonix treated patients to a control population ...
(Date:9/2/2014)... , September 2, 2014 ... Transparency Market Research "Latin America Home Healthcare Market ... Home Healthcare Devices, Mobility Assist Devices and Medical ... Therapy, Infusion Therapy and Unskilled Home Healthcare Services) ... Forecast, 2014 - 2020" the Latin American Home ...
Breaking Medicine Technology:Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6
... 2012  ASH is encouraged by the steps FDA ... significantly affected so many patients with hematololgic malignancies ... are consistent with the Society,s recommendations to FDA, ... agency,s authority to prevent drug shortages by requiring ...
... N.J., Feb. 21, 2012 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, ... announced that on January 31, 2012, its board of ... "Reverse Split") of the outstanding shares of the Company,s ... (1) share for every two (2) shares outstanding, so ...
Cached Medicine Technology:Statement from American Society of Hematology (ASH) President Armand Keating, MD, on FDA Action to Alleviate Drug Shortages 2American Oriental Bioengineering Inc. Announces Plans for Reverse Stock Split of its Common Stock 2
(Date:9/2/2014)... with less intensive (and expensive) practice patterns appear to ... patients unnecessary and excessive medical care, according to a ... "Growing concern about the costs and harms of medical ... avoid the provision of unnecessary care," said lead author ... Dartmouth Institute for Health Policy & Clinical Practice. ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Evolve ... within the primary and urgent care arena, is ... opening coincides with a health fair the clinic ... incorporating technology to assist patients in achieving high ... Medical Clinics’ pricing structure is a groundbreaking change ...
(Date:9/2/2014)... 2014 The first trial involving ... implant ( http://www.depuypinnacle-lawsuit.com/depuy-pinnacle-hip-implant/ ) will soon get underway, ... District Court, Northern District of Texas, Bernstein Liebhard ... Johnson and its DePuy Orthopaedics unit are facing ... caused recipients to suffer serious and debilitating complications. ...
(Date:9/2/2014)... 02, 2014 The exclusive ClinicCRM patient ... designed to help doctors manage foreign patient flow, enable ... conversion rates and clink revenue. Since its launch in ... in sales revenue and a 70 percent increase in ... their own healthcare practices. , With its ease of ...
(Date:9/2/2014)... California, San Diego School of Medicine have identified an ... The findings, reported in the current issue of PNAS, ... mortality worldwide. An estimated 40,000 women in America will ... American Cancer Society. , "The take-home message of the ... target breast cancer metastasis through a pathway regulated by ...
Breaking Medicine News(10 mins):Health News:Residency training predicts physicians' ability to practice conservatively 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 2Health News:Evolve Medical Clinics Announces Grand Opening of Annapolis, Maryland Location 3Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit Set For Trial in Federal Litigation, as Jury Selection Begins Today, Bernstein Liebhard LLP Reports 4Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 2Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 3Health News:Doctors Abroad Using VisitandCare.com Patient Management Software Report 60% Increase in Revenue 4Health News:Enzyme controlling metastasis of breast cancer identified 2
... But researcher stresses risk is still low , , MONDAY, Jan. ... the risk of developing brain cancer at a young age ... people with malignant brain tumors and 238 people with no ... most common type of brain cancer. Patients survive an average ...
... heart disease to rest , , MONDAY, Jan. 26 (HealthDay News) ... in vegetable oils, nuts and seeds possibly being bad for ... American Heart Association claims. , "There has been a lot ... might be bad," said William S. Harris, the nutritionist heading ...
... of American Physicians, Inc. Chief Executive Officer James L. ... Spirit of Life(R) Award, City of Hope,s ... celebrating Mr. Weidner and his award will be held ... Saturday, November 14. Spirit of Life(R) Award honorees ...
... Buy is Exclusive Retail Partner WARREN, N.J., Jan. ... VM ) announced today that it is joining ... of the LG Pink Flare limited edition handset, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090126/NY62794 ) , (Logo: ...
... Nephros, Inc. (Pink Sheets: NEPH), a medical device company ... control, and water purification, today announced that its common ... the symbol "NEPH." The Company also announced that ... the NYSE Alternext US LLC (formerly, the American Stock ...
... people tend to overestimate the dangers, study finds, , , ... the minds of U.S. minorities and the disabled more ... , Ethnic minorities, as well as the disabled and ... changes based on terrorism fears, such as avoiding certain ...
Cached Medicine News:Health News:Omega-6 Fatty Acids Can Be Good for You 2Health News:Omega-6 Fatty Acids Can Be Good for You 3Health News:James L. Weidner Named 2009 Spirit of Life(R) Award Recipient by City of Hope 2Health News:Virgin Mobile USA Launches Limited Edition Pink Flare Handset to Benefit Susan G. Komen for the Cure(R) 2Health News:Virgin Mobile USA Launches Limited Edition Pink Flare Handset to Benefit Susan G. Komen for the Cure(R) 3Health News:Nephros Common Stock Now Quoted in Pink Sheets 2Health News:Nephros Common Stock Now Quoted in Pink Sheets 3Health News:Terror Fears Tougher on Minorities, Disabled 2Health News:Terror Fears Tougher on Minorities, Disabled 3
...
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: